Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
N/A
-3,879 Reduced 97.49%
100 $0
Q4 2023

Feb 02, 2024

BUY
N/A
3,979 New
3,979 $1,000
Q2 2023

Aug 04, 2023

BUY
N/A
2,214 Added 40.0%
7,749 $14,000
Q1 2023

Apr 27, 2023

SELL
$1.3 - $2.15 $214 - $354
-165 Reduced 2.89%
5,535 $17,000
Q4 2022

Feb 02, 2023

BUY
$1.12 - $1.69 $5,264 - $7,943
4,700 Added 470.0%
5,700 $6,000
Q3 2022

Nov 04, 2022

SELL
$1.7 - $2.36 $647 - $899
-381 Reduced 27.59%
1,000 $1,000
Q2 2022

Aug 03, 2022

BUY
$1.8 - $6.45 $2,485 - $8,907
1,381 New
1,381 $2,000

Others Institutions Holding DNAY

# of Institutions
1
Shares Held
307
Call Options Held
0
Put Options Held
0

About Codex DNA, Inc.


  • Ticker DNAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,518,200
  • Market Cap $54.6M
  • Description
  • Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...
More about DNAY
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.